DoW Orthopaedic, Clinical Research Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The fiscal year 2026 Orthopaedic Research Program Clinical Research Award is designed to support clinical research that evaluates orthopaedic-specific factors and interventions with the goal of producing clinically actionable evidence to improve patient outcomes and inform healthcare practices or policies. Applications must demonstrate how the proposed work will positively affect patient care and reduce the impact of orthopaedic injuries and their consequences. The research outcomes are expected to benefit service members, their families, veterans, and the broader public. To be eligible, research must address at least one of the designated focus areas outlined for the award. The award features two distinct research levels. Research Level 1 (RL1) supports clinical research projects within focus areas including ligamentous trauma, osseointegration outcomes, return-to-duty strategies, and military women's health. Research Level 2 (RL2) supports clinical trials concentrated on ligamentous trauma, limb stabilization and protection, and return-to-duty strategies. This structure ensures targeted support for studies ranging from observational and exploratory clinical research to interventional trials aimed at directly influencing clinical practice in orthopaedics relevant to military and veteran populations.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Timeline
Organization & Contact Information
Full Description
Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury and sequela. The ORP expects that research findings benefit Service Members, their families, Veterans and the general public. To meet the intent of the award mechanism, applications must specifically address at least one of the FY26 ORP CRA Focus Areas.
Distinctive Features:
· The CRA offers two research levels.
Research Level 1 (RL1) supports clinical research in the following FY26 ORP focus areas:
· Ligamentous Trauma
· Osseointegration Outcomes
· Return-to-Duty Strategies
· Military Women’s Health
Research Level 2 (RL2) supports clinical trials in the following FY26 ORP focus areas:
· Ligamentous Trauma
· Limb Stabilization and Protection
· Return-to-Duty Strategies
